Skip to Main Content

Paper Details

Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
Front Immunol
15
2022
Author NameAffiliation
Rafael Delgado
Rafael DelgadoInstituto de Investigacion Hospital Universitario 12 de Octubre (imas12)
Rafael DelgadoUniversidad Complutense de Madrid
  • 1 - 3

Datasets

Release 1.2